期刊文献+

血清促生长激素释放激素受体配体(Ghrelin)水平与多囊卵巢综合征的相关性分析 被引量:1

血清促生长激素释放激素受体配体(Ghrelin)水平与多囊卵巢综合征的相关性分析
下载PDF
导出
摘要 目的通过检测PCOS患者血清Ghrelin水平,分析血清Ghrelin水平与人体测量学,内分泌激素,及胰岛素抵抗指标等指标的相关性,同时探讨PCOS患者测定血清Ghrelin水平的意义。方法选择97例PCOS患者,120名健康女性为对照组,测定血清Ghrelin水平、内分泌激素、血糖、血脂、胰岛素、身高、体重、腰臀围,采用统计学软件比较2组的差异。结果 PCOS组与对照组比较,PCOS组血清Ghreli水平低于正常对照组(P=0.039),有统计学差别,FSH、PRL、E2、FBG、CHO、TG、LDL等无统计学意义。但PCOS组WHR、LH和T水平明显高于对照组(P<0.01,P<0.01,P<0.01),BMI、HOMA-IR也高于对照组(P<0.05,P<0.05,P<0.05)。PCOS肥胖组Ghrelin水平低于PCOS非肥胖组(P<0.05);对照肥胖组低于对照非肥胖组(P<0.05)。而PCOS组中IR组血清Ghrelin水平低于非IR组(P<0.05),对照组中IR组血清Ghrelin水平显著低于IR组(P<0.01)。结论 PCOSPCOS患者血清Ghrelin水平较低,且Chrelin水平与胰岛素抵抗程度呈负相关,与脂代谢水平和性激素无相关性。 Objective To explore the relationship of ghrelin and human surveying,hormone,IR and other clinical Paramaters by dectecting these surum level of ghrelin,at the sam etime analyze the significance of serum ghrelin level in PCOS.Methods 97 patients with PCO were recruited,at the same time 40 women were selected as healthy cotirols.The serum ghreli nlevel,elinieal,hormone and metabolism diameters were deteeted in all subjects.All data analyiced with statistical analysis software.Results PCOS group compared with controls,PCOS group Ghreli levels below normal serum group(P=0.039),have statistical differences,FSH、PRL、E2、FBG、CHO and TG,LDL etc was statistically significant.But PCOS group WHR,LH and T level obviously higher than that of the control group(P0.01,P0.01,P0.01),BMI,HOMA a IR and also higher than that in control group(P0.05P,0.05,P0.05).PCOS obesity group Ghrelin levels below PCOS not obese group(P0.05).Contrast obesity group than controls the obesity group(P0.05). And PCOS group IR group serum Ghrelin levels below the IR group(P0.05),and the control group in IR group Ghrelin level of serum significantly below IR group(P0.01).Conclusion TheSenjm levels ghrelin were found to be Signifieantly deereased in wonlen with PCOS.Ghielin levels correalated in versely with BMI,WHR,HOMA-一IR,but no eorrelation was found between serum ghrelin leVel and hormone liPids.
作者 文璞 崔伟
出处 《中外医疗》 2010年第35期16-17,共2页 China & Foreign Medical Treatment
关键词 多囊卵巢综合征 促生长激素释放激素受体配体 胰岛素抵抗 Polyeystico Vary syndrom Ghrelin IR
  • 相关文献

参考文献4

二级参考文献16

  • 1Patel K,Coffler MS,Dahan MH,et al.Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.Clin Endocrinol (Oxf),2004,60:67-74.
  • 2Asuncion M,Calvo RM,San Millan JL,et al.A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.J Clin Endocrinol Metab,2000,85:2434-2438.
  • 3Bernard L,Christin-Maitre S,Basille C,et al.Insulin resistance and polycystic ovary syndrome.Gynecol Obstet Fertil,2003,31:109-116.
  • 4Diamanti-Kandarakis E,Kandarakis HA.Conservative management of gynecologic diseases: insulin sensitizing agents in polycystic ovary syndrome.Ann N Y Acad Sci,2003,997:322-329.
  • 5Dunaif A,Thomas A.Current concepts in the polycystic ovary syndrome.Annu Rev Med,2001,52:401-419.
  • 6Siegel S,Futterweit W,Davies TF,et al.A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome.Fertil Steril,2002,78:1240-1243.
  • 7The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Hum Reprod,2004,19:41-47.
  • 8Barontini M,Garcia-Rudaz MC,Veldhuis JD.Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome.Arch Med Res,2001,32:544-552.
  • 9VrbIkova J,Cibula D,Dvorakova K,et al.Insulin sensitivity in women with polycystic ovary syndrome.J Clin Endocrinol Metab,2004,89:2942-2945.
  • 10Vanky E,Kjotrod S,Salvesen KA,et al.Clinical,biochemical and ultrasonographic characteristics of Scandinavian women with PCOS.Acta Obstet Gynecol Scand,2004,83: 482-486.

共引文献32

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部